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Cellular cooperation between different lymphoid cell populations is a characteristic 
feature of many immune responses (1,  2). The classes of lymphoid cells which have 
been shown to collaborate have been divided into two major groups: thymus-derived 
(T cell)  1 and bone marrow-derived (B  cell) lymphocytes. Synergism between T  cell 
and  B  cell components  has  been  demonstrated  for  (a)  humoral  responses  against 
heterologous erythrocytes and serum proteins, (b) in "carrier-specificity" phenomena, 
and (c) in graft-vs.-host cell-mediated immunity (1). In addition, the demonstration of 
specific immunological memory and tolerance in T  cell-mediated cellular responses, 
and in B cell-mediated humoral responses, suggests that both populations contain cells 
which  are  capable of  displaying antigenic specificity (1).  With respect  to  humoral 
immunity, although both classes of cells can respond to an antigenic stimulus, only the 
B cell line can synthesize exportable immunoglobulin (3-5). T  ceils do not secrete anti- 
body, but appear to be necessary to facilitate antibody production by B cells. But the 
mechanism of interaction between these two populations in the immune response is not 
known. 
Recently, we reported that augmented responses similar to those after a second 
exposure to the same antigen need not be specific (6). Our data indicated that the 
addition of specific antigen to a population of primed cells results in the enhance- 
ment of the response to another unrelated antigen present in the environment. 
This is consistent with  the  idea,  suggested by Davies et  al.,  that  a  mediator, 
released by specifically  stimulated T  cells, acts on the antibody-producing B cells 
to increase their response. 
The experiments described here were designed to determine whether specific 
stimulation of cells from the thymus of primed mice results in augmentation of 
* Research Fellow of the American Heart Association. 
:~ Career Investigator of the American Heart Association. 
1 Abbreviations used in this paper: B cell, bone marrow-derived lymphocyte; PFC, plaque- 
forming cell; SRBC, sheep erythrocytes; T cell, thymus-derived lymphocyte; TT, fluid tetanus 
toxoid. 
THE  JOIYRNAL O~" EXPERIMENTAL MEDICINE • VOLUME 135,  1972  437 438  SPECIFIC  ENHANCEMENT  OF  IMMUNE  RESPONSES 
an immune response by normal spleen cells to an unrelated  antigen.  We added 
graded numbers of syngeneic thymocytes from mice primed with tetanus toxoid 
to suspension-cultures  of normal spleen cells which were stimulated  with sheep 
erythrocytes (SRBC). The addition of the priming antigen to such cultures re- 
sulted in significant enhancement of the anti-SRBC plaque-forming cell (PFC) 
response  compared  to aliquots  cultured  without  the  priming  antigen.  Similar 
cultures of normal thymocytes and normal spleen cells did not show this effect. 
6-wk-old DBA/2 female mice were immunized with  10 Lf of fluid tetanus  toxoid  (TT). 
Mice were shown to be primed, by finding antitoxin in their serum, as previously described (6). 
Cultures were prepared from the spleens of immunized and normal mice 30-60 days after injec- 
tion by a modification of the method of Mishell and Dutton (6). Suspensions of primed and 
normal thymocytes were prepared by excising the upper two-thirds of the thymic lobes, care 
being taken to avoid fascial tags which might contain lymph node tissue. Thymus lobes were 
teased apart and  treated  similarly to the spleen cell suspensions. Cells were resuspended in 
complete medium (6)  to a final concentration  of 20 million cells/ml. Experimental  cultures 
contained 20 million normal spleen cells and 10 million or 1 million primed or normal thymo- 
cytes. Uniform cell density was maintained in all groups of cultures. Cultures were stimulated 
with approximately 3 million SRBC on day 0 and with 1 ng/ml of TT on day 2. Cells releasing 
anti-SRBC hemolysins were enumerated on day 5 by a  modification of the direct technique of 
Jerne and Nordin (6). 
The results  of a  representative  group of experiments  are  shown  in Table I. 
Addition of 1 ng/ml  of TIT on day 2  to SRBC-stimulated,  normal spleen  cell 
cultures containing 10 million thymocytes primed with TT, resulted in a signifi- 
cant enhancement of the anti-SRBC PFC response compared to similar cultures 
without the priming antigen (groups 1 and 2). In contrast, the addition of TT to 
cultures  with  similar  numbers  of normal  spleen  cells  and  normal  thymocytes 
resulted  in  a  slight  depression  in  the  anti-SRBC  response  (groups  3  and  4). 
Addition of TT to positive control (groups 5 and 6) and negative control cultures 
(groups 7 and 8) resulted in significant augmentation or slight depression, respec- 
tively,  of the  PFC response,  as previously reported  (6). We obtained no anti- 
SRBC  plaques  in  SRBC-stimulated  cultures  of primed  or normal  thymocytes 
cultured in the presence of priming antigen nor in its absence (groups 9 and 10). 
To control for the possibility that  the  enhanced  response was due  to either 
lymph  node  cells  or peripheral  blood  lymphocytes contaminating  the  primed 
thymocyte  population,  we  performed  a  similar  experiment  substituting  10 
million  primed  spleen  cells  for  the  i0  million  primed  thymocytes  (Table  II, 
groups 9 and  10). Addition of TT to such cultures did not produce an elevated 
anti-SRBC  PFC  response  (Table  II,  experiments  4  and  5).  All  controls  re- 
sponded as shown in Table I. 
In another set of experiments, we measured the effect of adding TT on day 2 to 
mixed cultures of 1 million primed or normal thymocytes and 20 million normal 
spleen ceils that received SRBC on day 0. It can be seen that addition of priming 
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(Table II, experiments 1-3). Enhancement was observed in positive controls, 
while slight depression was seen in the negative controls. 
The  results  indicate  that  antigenic  stimulation  affects  a  relatively  small 
number of cells in the thymus in such a way that they respond specifically to it 
TABLE I 
Effect on the Anti-SRBC PFC Response of Adding 1 ng of TT on Day 2 to Mixed Cultures of 
10 Million TT-Primed Thymoeytes and 20 Million Normal Spleen Cells Stimulated with 
SRBC on Day 0 
Cultured cells (in 
Group  millions) 
I  10 Primed Thy 
20 Normal Spl* 
2  10 Primed Thy 
20 Normal Spl* 
3  10 Normal Thy 
20 Normal Spl* 
4  10 Normal Thy 
20 Normal Spl* 
5  20 Primed Spl 
6  20 Primed Spl 
7  20 Normal Spl 
8  20 Normal Spl 
9  20 Primed Thy 
10  20 Normal Thy 
TT 
+ 
+ 
+  1637 
(3411 
--  1223 
+  1070 
-241 
1413 
/~  or --  0 
or  0 
Anti-SRBC plaques per 10  6 recovered cells 
Experiment 
1 
1390 
(391 
1000 
983 
-ltl 
1103 
2 
1720 
(70) 
1010 
1187 
1--16) 
1420 
2220 
(50) 
1483 
1750 
(-2) 
1783 
0 
0 
3 
2363 
(38) 
1710 
1680 
(--18) 
2047 
2010 
(36) 
1483 
1960 
(--13) 
2247 
0 
0 
4 
3647 
(38) 
2640 
2846 
(--22) 
3640 
5130 
(48) 
3460 
3660 
(--II) 
4120 
0 
0 
3160 
(94)§ 
1627 
2352 
(--5) 
2467 
3367 
(66)§ 
2032 
2800 
(-3) 
2892 
Average 
enhancement 
of anti- 
SRBC PFC 
response 
56% 
-  14% 
47% 
-  i  1% 
Thy, thymocytes; Spl, spleen cells; TT, tetanus toxoid; Nos. in parentheses indicate degree 
of enhancement. 
* Similar results were obtained  with  I0 million spleen cells. 
:~ Symbols represent P values calculated by Student's  t test. P < 0.005 
§ p  <  0.001. 
II P  <  O.OLO. 
again on restimulation. This is  apparent from  the  data which show  that  the 
addition of TT to 10 million, but not 1 million TT-primed thymocytes, cultured 
with 20 million  normal spleen cells, enhances the anti-SRBC PFC response. 
The  data  support  the  concept  that  at  least  some  components of  antigen- 44(1  SPECIFIC  ENHANCEMENT  OF  IMMUNE  RESPONSES 
specific immunological memory reside in the T  cell population. These observa- 
tions are consistent with  the supposition  that  the capacity of thymus cells to 
collaborate with bone marrow cells in humoral responses can be specifically en- 
hanced by prior exposure of the thymocytes to the test antigen (7-10). Similar 
TABLE  II 
Effect on the Anti-SRBC PFC Response of Adding 1 ng of I'T on Day 2 to Mixed Cultures of 
l  Million TT-Primed Tl~ymocyles  (or 10 Million TT-Prim~:d Spleen Cells) and 20 Million 
Normal Spleen Cells Stimulated with SRBC on Day 0 
Group 
5 
6 
7 
8 
9 
10 
Cultured cells 
(in millions) 
1 Primed Thy 
20 Normal Spl 
1 Primed Thy 
20 Normal Spl 
1 Normal Thy 
20 Normal Spl 
1 Normal Thy 
20 Normal Spl 
+ 
i 
+ 
r 
TT 
20 Primed Spl  i  + 
1 
20 Primed Spl  i  _ 
! 
20 Normal Spt  i  + 
20 Normal Spl  ]  - 
10 Primed Spl  r  + 
20 Normal Spl  i 
10 Primed Spl  !  -- 
20 Normal Spl 
Anti-SRBC plaques per  10 6 recovered cells 
Fxperiment 
!  2  3 
3167  3440  3267 
(6)  (4)  (--14) 
2987  3427  3787 
2107  3233  3330 
(-35)  (--15)  (--2) 
3240  3807  3400 
!  5 
I .... 
2273  4060  !  3372  3453  3553 
(58)~  (33)§ I  (44)~!  (62)~  (67)~ 
1,443  3060  2347  2127  2127 
2067 
(-3) 
2127 
1620 
(-6) 
1727 
2467 
(--20) 
3073 
2640  3440 
(--17)  (--19) 
3200  4247 
2400 
(0) 
2407 
2413 
(4) 
2320 
Average 
enb&ncemen[ 
of anti- 
SRBC PFC 
response 
-  1% 
--  17% 
53% 
-12% 
-1% 
See Table I  for explanatory footnotes. 
findings of antigenic specificity and immunologicM memory of thymocytes have 
been reported in a  cell-mediated  graft-vs.-host system (ll).  Furthermore, the 
fact that the adoptive secondary response to hapten-protein conjugates can be 
abrogated by treatment of carrier-primed cells  (T cells)  with  anti-0 serum  is 
additional evidence that at least a portion of immunological memory resides in 
the T cell population (12). 
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Note  Added  in  Proof.--Using  the  carbon-injection  technique  of  Leckband  and 
Boyse (1971. Science (Washington). 172:1258),  we were unable  to detect parathymic 
lymph nodes adherent to, or within, the thymic capsule  of DBA/2 mice; hence, it  is 
unlikely that contaminating lymph node cells were responsible for the enhancing ef- 
fect observed in mixtures of primed thymocytes and spleen cells. 